Fewer Adults Eligible for Statins With PREVENT Equations

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 21, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 21, 2024 -- Use of the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations reduces the number of adults meeting criteria for primary prevention statin therapy compared with use of the 2013 pooled cohort equations (PCEs), according to a study published online June 10 in JAMA Internal Medicine.

Timothy S. Anderson, M.D., from the University of Pittsburgh, and colleagues conducted a cross-sectional study involving adults aged 40 to 75 years who participated in the National Health and Nutrition Examination Survey from 2017 to March 2020. National estimates of 10-year atherosclerotic cardiovascular disease (ASCVD) risk were compared using the 2013 PCEs and the PREVENT equations, developed in 2023.

The researchers found that 20.7 percent of the weighted sample of 3,785 U.S. adults without known ASCVD reported current statin use. The mean estimated 10-year ASCVD risk was 8.0 and 4.3 percent using the PCEs and PREVENT equations, respectively. Compared with the PCEs, the mean estimated 10-year ASCVD risk was lower using the PREVENT equations across all age, sex, and racial subgroups, with the largest difference seen for Black adults (10.9 versus 5.1 percent) and those aged 70 to 75 years (22.8 versus 10.2 percent). The number of adults meeting criteria for primary prevention statin therapy would be reduced from 45.4 to 28.3 million with use of the PREVENT equations instead of the PCEs. Based on the PREVENT equations, 44.1 percent of adults eligible for primary prevention statin therapy reported currently taking statins.

"Use of the PREVENT equations could result in 17.3 million patients no longer meeting criteria for primary prevention statin therapy," the authors write. "However, the majority of adults eligible for receiving such therapy based on PREVENT equations are not currently receiving statins."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-22 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords